Tezacaftor/Ivacaftor
VX15-661-112
Phase 3 small_molecule completed
Quick answer
Tezacaftor/Ivacaftor for Cystic Fibrosis is a Phase 3 program (small_molecule) at Vertex Pharmaceuticals (Ireland) Limited with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Vertex Pharmaceuticals (Ireland) Limited
- Indication
- Cystic Fibrosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed